← Leaderboards
Duane Ruffner
Symbion Discovery, Inc.
$400,816
Attributed
$601,911
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $468.1K · FY2010–11$500K$375K$250K$125K$0
'10
'11
Funding mix
By agency
NIH$601,911 · 2
By mechanism
R43$601,911 · 2
Top collaborators
- Robert Walter Buckheit2 shared
Others in their field
Top investigators on “Therapeutic Agents”
- David Heimbrook · Leidos Biomedical Research, Inc.$386,032,874
- Gregory H Reaman · National Childhood Cancer Foundation$247,684,034
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Sharon A Nachman · Johns Hopkins University$213,337,729
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$208,842,121
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$197,687,122
Research focus
Therapeutic AgentsToxic EffectPharmaceutical PreparationsTechnologyTherapeutic DevelopmentMemberGenetic EngineeringPathway InteractionsHigh Throughput ScreeningSolubilityLeadInnovationBaseLibrariesBiological FactorsDrug DiscoveryNew TechnologyEngineeringEscherichia ColiHarvestPropertyPublic Health RelevanceGenesHiv Therapy
Grant awards (3)
Discovery of drugs for use in the treatment and prevention of HIV infection using$133,859
R43 · FY2011 · AT · contact PI
Discovery of drugs for use in the treatment and prevention of HIV infection using$268,332
R43 · FY2010 · AT · contact PI
Trunkamide Optimization as a Demonstration of a Revolutionary Drug Discovery/Deve$199,720
R43 · FY2010 · GM · contact PI